loader
Please Wait
Applying Filters...
menu
    • menu

    Quality Alerts: Strides Pharma Sciences Received FDA Form 483 - Strides Pharma Science

    MenuStrides Pharma Science

    Uploaded: 2022
    News
    Strides Continues to Deliver Exceptional Highest Ever Q3FY26

    30 Jan 2026

    // PRESS RELEASE

    Strides Names Yajuvendra Singh M R VP Of Digital Transformation

    04 Jan 2026

    // INDPHARMAPOST

    Movement in Senior Management Personnel

    03 Dec 2025

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Strides Pharma Science

    Contact Supplier

    Website

    BePharma

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    https://www.youtube.com/embed/7gF-7DrPhBs?si=caG7E0TfIb5WPefw
    Xls

    CATEGORY PAGE
    Menu

    Strides Pharma Science

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC110726
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.